References

Sequential vs. concurrent chemoradiation for stage III non–small cell lung cancer: randomized phase III trial RTOG 9410

10.1093/jnci/djr325 · 2011 · External reference

Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non–small-cell lung cancer

10.1200/jco.2009.26.2543 · 2010 · External reference

Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide

10.1056/nejm199901283400403 · 1999 · External reference

Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy

10.1016/j.ijrobp.2004.12.025 · 2005 · External reference

Systematic review of dose-volume parameters in the prediction of esophagitis in thoracic radiotherapy

10.1016/j.radonc.2008.09.010 · 2009 · External reference

Risk factors for acute esophagitis in non–small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy

10.1016/j.ijrobp.2006.04.022 · 2006 · External reference

Predictors of radiation-induced esophageal toxicity in patients with non–small-cell lung cancer treated with three-dimensional conformal radiotherapy

10.1016/s0360-3016(02)03937-8 · 2003 · External reference

Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: An international individual patient data meta-analysis

10.1016/j.ijrobp.2012.04.043 · 2013 · External reference

A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data

10.1016/j.ijrobp.2007.04.077 · 2007 · External reference

Analysis of radiation pneumonitis risk using a generalized Lyman model

10.1016/j.ijrobp.2008.04.053 · 2008 · External reference

Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer

10.1016/s0360-3016(01)01685-6 · 2001 · External reference

Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)

10.1016/s0360-3016(99)00183-2 · 1999 · External reference

10.1016/s1470-2045(14)71207-0

10.1016/s1470-2045(14)71207-0 · 2015 · External reference

Influence of technologic advances on outcomes in patients with unresectable, locally advanced non–small-cell lung cancer receiving concomitant chemoradiotherapy

10.1016/j.ijrobp.2009.02.032 · 2010 · External reference

A population-based comparative effectiveness study of radiation therapy techniques in stage III non–small cell lung cancer

10.1016/j.ijrobp.2013.12.010 · 2014 · External reference

A population-based study of primary chemoradiotherapy in clinical stage III non–small cell lung cancer: Intensity-modulated radiotherapy versus 3D conformal radiotherapy

2014 · External reference

Comparative effectiveness of intensity-modulated versus 3D conformal radiation therapy among medicare patients with stage III lung cancer

10.1097/jto.0000000000000331 · 2014 · External reference

Effect of radiation therapy techniques on outcome in N3-positive IIIB non–small cell lung cancer treated with concurrent chemoradiotherapy

10.4143/crt.2014.131 · 2016 · External reference

Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer

10.1002/cncr.25848 · 2011 · External reference

Limiting the risk of cardiac toxicity with esophageal-sparing intensity modulated radiotherapy for locally advanced lung cancers

10.21037/jtd.2016.03.64 · 2016 · External reference

Potential for reduced toxicity and dose escalation in the treatment of inoperable non–small-cell lung cancer: A comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation

10.1016/s0360-3016(03)00743-0 · 2003 · External reference

Phase 1 dose escalation study of accelerated radiation therapy with concurrent chemotherapy for locally advanced lung cancer

10.1016/j.ijrobp.2015.09.007 · 2015 · External reference

Unresolved reference

2010 · External reference

Non–small cell lung cancer, version 6.2015

10.6004/jnccn.2015.0071 · 2015 · External reference

Predicting esophagitis after chemoradiation therapy for non–small cell lung cancer: an individual patient data meta-analysis

10.1016/j.ijrobp.2013.07.029 · 2013 · External reference

Estimation of tumor control probability model parameters from 3-D dose distributions of non–small cell lung cancer patients

10.1016/s0169-5002(99)00019-7 · 1999 · External reference

Is IMRT superior or inferior to 3DCRT in radiotherapy for NSCLC? A meta-analysis

10.1371/journal.pone.0151988 · 2016 · External reference